Mesterobolic – Mesterolone 25 mg | 100 Tablets – Nitro Pro Bolic
1. Product Overview
Mesterobolic is presented as a Nitro Pro Bolic-branded oral tablet product containing mesterolone, a synthetic androgen structurally derived from dihydrotestosterone (DHT).
According to the supplied Roidsdeal and Finest Gears descriptions, each tablet contains a declared 25 mg of mesterolone, with 100 tablets supplied per pack.
Based on these specifications, the total calculated active ingredient content is 2,500 mg per pack.
Mesterolone is an orally active androgen that interacts with androgen receptors and influences hormone-responsive physiological processes.
It has a history of prescription medical use in certain countries, particularly in selected male androgen-deficiency and reproductive-health contexts.
However, its approved indications, availability, and regulatory status vary by jurisdiction.
Mesterolone is not an FDA-approved human medication in the United States.
Unlike many oral anabolic-androgenic steroids, mesterolone is not a conventional 17-alpha-alkylated compound.
Its chemical structure includes a 1-alpha-methyl modification associated with oral pharmacological activity.
Nevertheless, oral activity does not establish that mesterolone is free from hepatic, cardiovascular, endocrine, or reproductive risks.
The supplied Roidsdeal and Finest Gears descriptions emphasize product quality, precise tablet content, and consistent results.
However, these claims are not supported by independently verified laboratory reports in the supplied material.
This description provides a scientifically oriented overview of the declared product, its pharmacological characteristics, historical medical context, and relevant safety considerations.
2. What Is Mesterobolic?
Mesterobolic is the commercial name used for a mesterolone tablet product associated with Nitro Pro Bolic.
Mesterolone is a synthetic androgen derived from dihydrotestosterone.
It belongs to the broader anabolic-androgenic steroid category, although its pharmacological profile is predominantly androgenic rather than strongly anabolic.
Mesterolone has historically been marketed under prescription brand names such as Proviron in certain countries.
However, the presence of the same active ingredient does not establish that Mesterobolic is the original branded medication or an equivalent authorized pharmaceutical preparation.
Mesterolone acts through androgen receptors in hormone-responsive tissues.
Its biological activity is associated with androgenic signaling and related endocrine processes.
Because mesterolone is derived from DHT, it is not generally considered to undergo aromatization into estrogenic compounds.
However, this does not eliminate potential adverse effects associated with androgen exposure.
The product described here has a declared strength of 25 mg per tablet and a quantity of 100 tablets.
The actual composition, manufacturing quality, and regulatory authorization of this specific product have not been independently established.
3. How Does Mesterolone Work?
Mesterolone produces pharmacological effects primarily through androgen receptor activation.
Androgen Receptor Activity
Mesterolone interacts with androgen receptors in androgen-responsive tissues.
These receptors participate in the regulation of biological processes involving reproductive physiology, secondary sexual characteristics, and other hormone-dependent functions.
Dihydrotestosterone-Derived Structure
Mesterolone is structurally related to dihydrotestosterone.
DHT-derived androgens differ from testosterone in certain metabolic pathways and tissue-specific effects.
Mesterolone’s androgenic profile is influenced by this structural relationship.
Oral Pharmacological Activity
Mesterolone contains a 1-alpha-methyl structural modification.
This modification contributes to its oral pharmacological activity.
It differs from the 17-alpha-alkylation found in certain other oral anabolic steroids.
However, the absence of conventional 17-alpha-alkylation should not be interpreted as a guarantee of liver safety.
Androgenic Hormonal Signaling
Mesterolone influences androgen-responsive physiological pathways.
Its effects depend on receptor activity, individual hormonal status, and other biological factors.
Sex Hormone-Binding Globulin Interactions
Mesterolone has been investigated for its interaction with sex hormone-binding globulin (SHBG).
However, these interactions should not be presented as proof that the product safely or predictably increases clinically beneficial free testosterone levels.
Endocrine Feedback
Exogenous androgen exposure can influence the hypothalamic-pituitary-gonadal axis.
The degree of endocrine suppression may vary with the compound, exposure, and individual characteristics.
Therefore, claims that mesterolone cannot affect natural hormone production would be inappropriate.
4. Medical Uses & Clinical Information
Mesterolone has a history of prescription medical use in certain countries.
However, the specific indications and prescribing requirements depend on jurisdiction.
Male Androgen-Deficiency Conditions
Mesterolone has been used in selected medical settings involving male androgen deficiency.
Its androgen receptor activity has contributed to its historical therapeutic applications.
However, treatment decisions depend on the underlying diagnosis, clinical evaluation, and applicable prescribing information.
Male Reproductive-Health Research
Mesterolone has historically been investigated and used in selected male reproductive-health contexts.
However, evidence for specific fertility-related outcomes is limited and should not be interpreted as establishing universal effectiveness.
Exogenous androgen exposure may also affect normal reproductive endocrine function.
Androgen Receptor Research
Mesterolone is relevant to scientific investigations involving androgen receptor signaling and hormone-responsive tissues.
Its DHT-derived structure provides a distinct pharmacological profile compared with testosterone and certain other synthetic androgens.
Sex Hormone-Binding Globulin Research
Mesterolone has been investigated for its interactions with SHBG and related hormone-binding processes.
These observations contribute to understanding androgen pharmacology.
However, changes in hormone-binding measurements do not necessarily establish improved clinical outcomes.
Bodybuilding and Performance Claims
Mesterolone is sometimes discussed in nonmedical bodybuilding and athletic contexts.
However, these applications are not established as safe or approved therapeutic uses.
Mesterolone is prohibited in competitive sport under applicable WADA anti-doping rules.
Clinical Limitations
The supplied product descriptions do not include clinical studies evaluating this particular Mesterobolic preparation.
They also do not establish its bioequivalence to any authorized prescription mesterolone product.
Therefore, historical medical use of mesterolone should not be interpreted as evidence that Mesterobolic is an approved or clinically validated medication.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Mesterobolic |
| Brand | Nitro Pro Bolic |
| Listed Manufacturer | Nitro Pro Bolic |
| Manufacturer Verification | Required |
| Active Ingredient | Mesterolone |
| Compound Classification | Synthetic Androgen / Anabolic-Androgenic Steroid |
| Structural Classification | Dihydrotestosterone Derivative |
| Chemical Characteristic | 1-Alpha-Methylated Androgen |
| Declared Strength | 25 mg per Tablet |
| Dosage Form | Oral Tablets |
| Package Quantity | 100 Tablets |
| Packaging Type | Pack; Exact Container Not Specified |
| Calculated Total Active Content | 2,500 mg (2.5 g) |
| Product Category | Oral Androgens |
| Aromatization | Not Generally Considered Significant |
| FDA-Approved Human Use | No |
| Medical Authorization Elsewhere | Jurisdiction-Dependent |
| WADA Status | Prohibited |
| Batch-Specific COA | Not Provided |
| Actual Ingredient Content | Not Independently Verified |
| Manufacturing Quality | Not Independently Verified |
Both supplied sources identify mesterolone as the active ingredient.
Both also agree on the declared 25 mg strength and 100-tablet quantity.
The brand is consistently identified as Nitro Pro Bolic.
However, Finest Gears uses the Spanish word “cápsula” in one sentence, even though the product is otherwise described as tablets.
This appears to be a dosage-form terminology error.
The final product should be identified as tablets unless authentic packaging demonstrates otherwise.
The original sources also claim precise tablet content and guaranteed product quality.
No batch-specific laboratory documentation has been supplied to substantiate these claims.
6. Administration & Medical Supervision
Mesterobolic is presented in oral tablet form.
Mesterolone is a pharmacologically active synthetic androgen.
Its historical medical applications have involved prescription supervision in certain jurisdictions.
The supplied product descriptions do not establish an approved dosing regimen for this specific Mesterobolic product.
The declared 25 mg strength represents the amount of mesterolone claimed per tablet.
It does not establish a recommended dose or treatment schedule.
No self-administration regimen, bodybuilding protocol, or performance-enhancement schedule is supported by the supplied information.
Medical evaluation of androgen therapy may involve hormonal status, reproductive health, cardiovascular risk, and other relevant clinical factors.
Individuals seeking treatment for androgen deficiency or reproductive-health conditions should rely on appropriately authorized medications and qualified healthcare professionals.
The actual ingredient content and pharmaceutical quality of this commercial product have not been independently verified.
7. Possible Side Effects & Safety Limitations
Mesterolone can produce adverse effects associated with androgen receptor activity.
Androgenic Adverse Effects
Potential effects include:
- Acne
- Oily skin
- Increased body or facial hair growth
- Hair loss in susceptible individuals
- Other androgen-related skin and hair changes
Reproductive and Endocrine Effects
Potential concerns include:
- Changes in reproductive hormone regulation
- Alterations in libido
- Effects on fertility
- Endocrine disturbances
- Potential suppression of endogenous hormone production
Cardiovascular and Metabolic Effects
Androgen exposure may contribute to:
- Adverse blood lipid changes
- Cardiovascular risk factors
- Blood pressure-related concerns
- Other metabolic effects depending on individual susceptibility
Prostate-Related Concerns
Androgenic medications may require additional caution in individuals with certain prostate-related conditions.
Effects in Females
Exposure to androgenic compounds may cause virilization, including voice changes, increased body hair, and menstrual disturbances.
Some androgenic changes may be irreversible.
Liver-Related Considerations
Mesterolone differs structurally from conventional 17-alpha-alkylated oral anabolic steroids.
However, this difference does not establish the absence of liver-related risks.
The actual safety profile of this independently marketed product has not been established through supplied clinical or laboratory documentation.
8. Warnings & Precautions
Mesterolone is a pharmacologically active androgen.
Its use may require medical supervision and jurisdiction-specific prescription authorization.
Individuals with prostate-related conditions, cardiovascular disease, liver disorders, or other relevant medical conditions may require additional precautions.
Exogenous androgen exposure can affect reproductive and endocrine function.
Mesterolone should not be assumed suitable for women, adolescents, or individuals with undiagnosed hormonal conditions.
Exposure during pregnancy may cause serious developmental harm.
Mesterolone is prohibited in competitive sport under WADA regulations.
It is not FDA-approved for human therapeutic use in the United States.
The supplied descriptions claim guaranteed quality, precise tablet content, and superior results.
However, these claims have not been independently substantiated.
Product authenticity, actual ingredient strength, manufacturing quality, and regulatory authorization require verification.
9. Storage & Handling
Mesterobolic is described as a pack containing 100 oral tablets.
The supplied sources do not establish verified manufacturer storage temperatures, expiration requirements, or stability data.
Storage should follow authentic manufacturer labeling when available.
General tablet-handling considerations include protection from excessive moisture, heat, and environmental exposure.
Keep the product in its original, clearly identified packaging.
Avoid transferring tablets into unmarked containers.
The product should remain inaccessible to children and pets.
Products with damaged packaging, uncertain labeling, or unverified storage history should not be assumed to retain their declared composition or stability.
Batch information and expiration dates should be confirmed through authentic product documentation.
10. Frequently Asked Questions (FAQs)
What is Mesterobolic?
Mesterobolic is a Nitro Pro Bolic-branded oral tablet product containing mesterolone, a synthetic androgen derived from dihydrotestosterone.
How much mesterolone does each tablet contain?
According to both supplied sources, each tablet contains a declared 25 mg of mesterolone.
How many tablets are included in one pack?
The product is described as containing 100 tablets per pack.
Is mesterolone the same as Proviron?
Proviron is a recognized trade name associated with prescription mesterolone products in certain countries. However, Mesterobolic has not been established as the same branded product or a therapeutically equivalent authorized formulation.
Is Mesterobolic FDA-approved for human use?
No FDA approval has been established for Mesterobolic, and mesterolone is not an FDA-approved human medication in the United States.
11. Conclusion & Medical Disclaimer
Mesterobolic is presented as a Nitro Pro Bolic-branded oral tablet product containing a declared 25 mg of mesterolone per tablet, with 100 tablets per pack.
Mesterolone is a synthetic DHT-derived androgen with pharmacological activity involving androgen receptor signaling and hormone-responsive physiological processes.
It has a history of prescription medical use in certain countries, but its approved indications and regulatory status vary by jurisdiction.
The supplied Roidsdeal and Finest Gears descriptions agree on the active ingredient, declared strength, package quantity, and brand.
However, the original descriptions contain unsupported claims regarding guaranteed quality, precise tablet content, and superior results.
They also contain a minor dosage-form terminology inconsistency.
Manufacturer identity, actual ingredient strength, product authenticity, batch-specific laboratory testing, and regulatory authorization require independent verification.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, dosage guidance, or a recommendation for nonmedical androgen use, bodybuilding, athletic performance enhancement, or treatment of any medical condition.





Reviews
There are no reviews yet.